Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 7, 2013, Pages

  Slaughter, Tiffani N ^a   Paige, Adrienne ^a   Spires, Denisha ^a   Kojima, Naoki ^a   Kyle, Patrick B ^b   Garrett, Michael R ^a   Roman, Richard J ^a   Williams, Jan M ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Dahl S rats; Diabetes associated renal disease; Glomerulosclerosis; Hyperfiltration; Renal fibrosis; Renal hemodynamics; Streptozotocin; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

DAHL S RATS; DIABETES-ASSOCIATED RENAL DISEASE; GLOMERULOSCLEROSIS; HYPERFILTRATION; RENAL FIBROSIS; RENAL HEMODYNAMICS; STREPTOZOTOCIN; TYPE 1 DIABETES;

ANIMALS; ARTERIAL PRESSURE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUG IMPLANTS; FIBROSIS; GLOMERULAR FILTRATION RATE; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; MALE; PROTEINURIA; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TIME FACTORS;

EID: 84884959780     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00382.2012     Document Type: Article

References (36)

1. Allen TJ, Cao Z, Youssef S, Hulthen UL, Cooper ME. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes 46: 1612-1618, 1997.
2. + intake and early hypertension in Dahl rats. Jpn Heart J 20: 138-140, 1979.
3. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T, and the Animal Models of Diabetic Complications Consortium. Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512, 2009.
4. Chang SY, Chen YW, Chenier I, Tran Sle M, Zhang SL. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp Diabetes Res 2011: 521076, 2011.
5. Chen PY, St John PL, Kirk KA, Abrahamson DR, Sanders PW. Hypertensive nephrosclerosis in the Dahl/Rapp rat. Initial sites of injury and effect of dietary L-arginine supplementation. Lab Invest 68: 174-184, 1993.
6. Cooper ME, Allen TJ, Macmillan P, Bach L, Jerums G, Doyle AE. Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertens 1: 5-10, 1988.
7. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE. Effects of genetic hypertension on diabetic nephropathy in the rat-functional and structural characteristics. J Hypertens 6: 1009-1016, 1988.
8. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, Roman RJ. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 45: 643-648, 2005.
9. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, Roman RJ. Antihypertensive effects of chronic anti-TGF-antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 283: R757-R767, 2002.
10. Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, Kawachi H, Allen TJ, Cooper ME. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47: 89-97, 2004.
11. Elmarakby AA, Faulkner J, Baban B, Saleh MA, Sullivan JC. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am J Physiol Renal Physiol 302: F791-F800, 2012.
12. Elmarakby AA, Faulkner J, Baban B, Sullivan JC. Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int J Hypertens 2012: 957235, 2012.
13. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. The familial risk of end-stage renal disease in African-Americans. Am J Kidney Dis 21: 387-393, 1993.
14. Ge Y, Fan F, Murphy SR, Williams JM, Liu R, Falck J, Roman RJ. Deficiency in the production of 20-HETE contributes to impaired myogenic and TGF responses in the afferent arteriole of Dahl S rats (Abstract 36). Hypertension 60: A36, 2012.
15. Hayashi K, Epstein M, Saruta T. Altered myogenic responsiveness of the renal microvasculature in experimental hypertension. J Hypertens 14: 1387-1401, 1996.
16. Kang MJ, Ingram A, Ly H, Thai K, Scholey JW. Effects of diabetes and hypertension on glomerular transforming growth factor-beta receptor expression. Kidney Int 58: 1677-1685, 2000.
17. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91: 1464-1474, 1984.
18. Korner A, Jaremko G, Eklof AC, Aperia A. Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats. Diabetologia 40: 367-373, 1997.
19. Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, Kaldunski ML, Kotchen JM, Roman RJ. Glomerular hyperfiltration in hypertensive African-Americans. Hypertension 35: 822-826, 2000.
20. Manigrasso MB, Sawyer RT, Marbury DC, Flynn ER, Maric C. Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 301: F634-F640, 2011.
21. Mankhey RW, Bhatti F, Maric C. 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288: F399-F405, 2005.
22. Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738-744, 1978.
23. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF. Lovastatin but not enalapril reduces glomerular injury in Dahl saltsensitive rats. Hypertension 20: 651-658, 1992.
24. Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 24: 752-757, 1994.
25. Prabhu A, Xu Q, Manigrasso MB, Biswas M, Flynn E, Iliescu R, Lephart ED, Maric C. Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids 75: 779-787, 2010.
26. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984.
27. Roman RJ, Alonso-Galicia M, Wilson TW. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl saltsensitive rats. Am J Hypertens 10: 63S-67S, 1997.
28. Roman RJ, Ma YH, Frohlich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension 21: 985-988, 1993.
29. Takenaka T, Forster H, De Micheli A, Epstein M. Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res 71: 471-480, 1992.
30. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286: F8-F15, 2004.
31. Tolins JP, Raij L. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 16: 452-461, 1990.
32. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63: 209-216, 2003.
33. Williams JM, Sarkis A, Hoagland KM, Fredrich K, Ryan RP, Moreno C, Lopez B, Lazar J, Fenoy FJ, Sharma M, Garrett MR, Jacob HJ, Roman RJ. Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury. Am J Physiol Renal Physiol 295: F1764-F1777, 2008.
34. Wilson TW, Alonso-Galicia M, Roman RJ. Effects of lipid-lowering agents in the Dahl salt-sensitive rat. Hypertension 31: 225-231, 1998.
35. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26: 2392-2399, 2003.
36. Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndrome 1: 10, 2009.